The Design and Rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE)

Heart Lung and Circulation

Volumn 22, Issue 7, 2013, Pages 533-541

  Aliprandi Costa, B ^a   Ranasinghe, I ^a   Turnbull, F ^b   Brown, A ^c   Kritharides, L ^a   Patel, A ^b   Chew, D ^d   Walters, D ^e   Rankin, J ^f   Ilton, M ^g   Meredith, I ^h   Cass, A ^b   Brieger, D ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g ROYAL DARWIN HOSPITAL   (Australia)

^h MONASH MEDICAL CENTRE   (Australia)

Author keywords

Acute coronary syndromes; Comparative effectiveness; Process measures; Quality of care; Registry

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; AUSTRALIA; COMPARATIVE EFFECTIVENESS; CONFIDENTIALITY; COOPERATIVE NATIONAL REGISTRY OF ACUTE CORONARY CARE GUIDELINE ADHERENCE AND CLINICAL EVENTS; DEMOGRAPHY; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; FUNDING; HOSPITAL CARE; INFORMATION PROCESSING; MEDICAL ETHICS; MEDICAL HISTORY; PATIENT INFORMATION; PRIORITY JOURNAL; PRIVACY; QUALITY CONTROL; REGISTRATION;

ACUTE CORONARY SYNDROME; AUSTRALIA; COHORT STUDIES; DATABASES, FACTUAL; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; REGISTRIES;

EID: 84879499070     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.12.013     Document Type: Article

References (40)

1. Australian Institute of Health and Welfare Canberra Monitoring acute coronary syndrome using national hospital data: an information paper on trends and issues 2011 2011, Australian Institute of Health and Welfare, Canberra.
2. The shifting burden of cardiovascular disease in Australia. Access Economics and The National Heart Foundation of Australia; 2005.
3. Mathers C.D., Vos E.T., Stevenson C.E., Begg S.J. The burden of disease and injury in Australia. Bull World Health Organ 2001, 79(11):1076-1084.
4. Aliprandi-Costa B., Ranasinghe I., Chow V., Kapila S., Juergens C., Devlin G., et al. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000-2007. Med J Aust 2011, 195(3):116-121.
5. Chew D.P., Amerena J., Coverdale S., Rankin J., Astley C., Brieger D. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Int Med J 2007, 37(11):741-748.
6. Ranasinghe I., Alprandi-Costa B., Chow V., Elliott J.M., Waites J., Counsell J.T., et al. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. Am J Cardiol 2011, 108(5):617-624.
7. Scott I., Derhy P.H., O'Kane D., Lindsay K.A., Atherton J., Jones M.A., et al. Discordance between level of risk and intensity of evidence-based treatment in patients with acute coronary syndromes. Med J Aust 2007, 187(3):153-159.
8. Ranasinghe I, Brieger D, Aliprandi-Costa B. CONCORDANCE report on cardiac rehabiliatation services to the AIHW CONCORD Hospital; 2011.
9. Briffa T.G., Maiorana A., Sheerin N.J., Stubbs A.G., Oldenburg B.F., Sammel N.L., et al. Physical activity for people with cardiovascular disease: recommendations of the National Heart Foundation of Australia. Med J Aust 2006, 184(2):71-75.
10. Scott I.A., Thomson P.L., Narasimhan S. Comparing risk-prediction methods using administrative or clinical data in assessing excess in-hospital mortality in patients with acute myocardial infarction. Med J Aust 2008, 188(6):332-336.
11. Duckett S.J., Coory M., Sketcher-Baker K. Identifying variations in quality of care in Queensland hospitals. Med J Aust 2007, 187(10):571-575.
12. Pitches D.W., Mohammed M.A., Lilford R.J. What is the empirical evidence that hospitals with higher-risk adjusted mortality rates provide poorer quality care? A systematic review of the literature. BMC Health Serv Res 2007, 7:91.
13. Scott I.A., Brand C.A., Phelps G.E., Barker A.L., Cameron P.A. Using hospital standardised mortality ratios to assess quality of care-proceed with extreme caution. Med J Aust 2011, 194(12):645-648.
14. Brieger D., Kelly A.M., Aroney C., Tideman P., Freedman S.B., Chew D., et al. Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust 2009, 191(6):334-338.
15. Gallagher M.P., Krumholz H.M. Public reporting of hospital outcomes: a challenging road ahead. Med J Aust 2011, 194(12):658-660.
16. Chew D.P., Amerena J.V., Coverdale S.G., Rankin J.M., Astley C.M., Soman A., et al. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. Med J Aust 2008, 188(12):691-697.
17. Granger C.B. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol 2000, 86(12B):4M-9M.
18. Gregor R.D., Bata I.R., Brownell B., Wolf H.K. Trends in the in-hospital treatment of acute myocardial infarction between 1984 and 1993 - The Halifax County MONICA Project. Can J Cardiol 2000, 16(5):596-603.
19. Fox K.A., Cokkinos D.V., Deckers J., Keil U., Maggioni A., Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000, 21(17):1440-1449.
20. Steg P.G., Lopez-Sendon J., Lopez de Sa E., Goodman S.G., Gore J.M., Anderson F.A., et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007, 167(1):68-73.
21. Hutchison A.W., Malaiapan Y., Jarvie I., Barger B., Watkins E., Braitberg G., et al. Prehospital 12-lead ECG to triage ST-elevation myocardial infarction and emergency department activation of the infarct team significantly improves door-to-balloon times: ambulance Victoria and MonashHEART Acute Myocardial Infarction (MonAMI) 12-lead ECG project. Circ Cardiovasc Interv 2009, 2(6):528-534.
22. Willson A.B., Mountain D., Jeffers J.M., Blanton C.G., McQuillan B.M., Hung J., et al. Door-to-balloon times are reduced in ST-elevation myocardial infarction by emergency physician activation of the cardiac catheterisation laboratory and immediate patient transfer. Med J Aust 2010, 193(4):207-212.
23. Weeraratne J.I. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006, 185(9):526-527. [author reply 527].
24. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001, 141(2):190-199.
25. Moss E.A. Developing national health information in Australia. Medinfo 1995, 8(Pt 2):1636.
26. EQ-5D™. http://www.euroqol.org/.
27. Bufalino V.J., Masoudi F.A., Stranne S.K., Horton K., Albert N.M., Beam C., et al. The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation 2011, 123(19):2167-2179.
28. Shah B.R., Drozda J., Peterson E.D. Leveraging observational registries to inform comparative effectiveness research. Am Heart J 2010, 160(1):8-15.
29. Li S.Q., Gray N., Guthridge S., Pircher S., Wang Z., Zhao Y. Avoidable mortality trends in Aboriginal and non-Aboriginal populations in the Northern Territory, 1985-2004. Aust N Z J Public Health 2009, 33(6):544-550.
30. Beygui F., Silvain J., Pena A., Bellemain-Appaix A., Collet J.P., Drexler H., et al. Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Am J Cardiol 2010, 106(5):650-658.
31. Eikelboom J.W., Hankey G.J., Thom J., Bhatt D.L., Steg P.G., Montalescot G., et al. Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation 2008, 118(17):1705-1712.
32. Shishehbor M.H., Brennan M.L., Aviles R.J., Fu X., Penn M.S., Sprecher D.L., et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003, 108(4):426-431.
33. Mori K., Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007, 71(10):967-970.
34. Simon T., Verstuyft C., Mary-Krause M., Quteineh L., Drouet E., Meneveau N., et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009, 360(4):363-375.
35. Gao L.B., Zhou B., Zhang L., Wei Y.S., Wang Y.Y., Liang W.B., et al. R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome. BMC Med Genet 2008, 9:74.
36. Palmer B.R., Jarvis M.D., Pilbrow A.P., Ellis K.L., Frampton C.M., Skelton L., et al. Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am Heart J 2008, 156(4):752-758.
37. May L. The National E-Health Transition Authority (NEHTA). HIM J 2005, 34(1):19-20.
38. Marko N.F., Weil R.J. The role of observational investigations in comparative effectiveness research. Value Health 2010, 13(8):989-997.
39. Operating Standards for Australian Clinical Quality Registries. 2008. http://www.safetyandquality.gov.au/internet/safety/publishing.nsf/Content/PriorityProgram-08_clinical.
40. Sox H.C., Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 2009, 151(3):203-205.